Clinical Trial Details
EORTC-55881
Back to Clinical Trials Database
Phase II trial of Fotemustine (S 100360) in patients with advanced ovarian carcinoma
Trial Status | All trial activities ended |
---|---|
Dates |
Date of activation: 01-Apr-1989 Date Step1 close: 01-Dec-1989 |
Data management at EORTC | Yes |
Design |
Phase 2 Randomized open label |
Targeted Sample size | EORTC Groups: 20 |
Treatment | |
Study Staff | |
Type of cancer | |
Participating groups | |
Protocol summary | http://clinicaltrials.gov/study/ |
NCT number |